After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth Patrick Branch Read more
Related Practice Life Sciences & Pharma After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth. 10262020171018
Executive Insights Biotech and Pharmaceuticals The Hub-and-Spoke Model: An Emerging Biopharma Trend May 6, 2022
Article Mental and Behavioral Health A Test of Resilience: Looking Forward to Psychedelics Funding in 2023 March 7, 2023